Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Maternal obesity and metabolic disorders associate with congenital heart defects in the offspring: A systematic review

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Harvard

Hedermann, G, Hedley, PL, Thagaard, IN, Krebs, L, Ekelund, CK, Sørensen, TIA & Christiansen, M 2021, 'Maternal obesity and metabolic disorders associate with congenital heart defects in the offspring: A systematic review', PLoS One, bind 16, nr. 5, e0252343, s. 1-22. https://doi.org/10.1371/journal.pone.0252343

APA

Hedermann, G., Hedley, P. L., Thagaard, I. N., Krebs, L., Ekelund, C. K., Sørensen, T. I. A., & Christiansen, M. (2021). Maternal obesity and metabolic disorders associate with congenital heart defects in the offspring: A systematic review. PLoS One, 16(5), 1-22. [e0252343]. https://doi.org/10.1371/journal.pone.0252343

CBE

MLA

Vancouver

Author

Hedermann, Gitte ; Hedley, Paula L ; Thagaard, Ida N ; Krebs, Lone ; Ekelund, Charlotte Kvist ; Sørensen, Thorkild I A ; Christiansen, Michael. / Maternal obesity and metabolic disorders associate with congenital heart defects in the offspring : A systematic review. I: PLoS One. 2021 ; Bind 16, Nr. 5. s. 1-22.

Bibtex

@article{5f43b22610cd4d22836ce4b4caf68850,
title = "Maternal obesity and metabolic disorders associate with congenital heart defects in the offspring: A systematic review",
abstract = "BACKGROUND: Congenital heart defects (CHDs) are the most common congenital malformations. The aetiology of CHDs is complex. Large cohort studies and systematic reviews and meta-analyses based on these have reported an association between higher risk of CHDs in the offspring and individual maternal metabolic disorders such as obesity, diabetes, hypertension, and preeclampsia, all conditions that can be related to insulin resistance or hyperglycaemia. However, the clinical reality is that these conditions often occur simultaneously. The aim of this review is, in consequence, both to evaluate the existing evidence on the association between maternal metabolic disorders, defined as obesity, diabetes, hypertension, preeclampsia, dyslipidaemia and CHDs in the offspring, as well as the significance of combinations, such as metabolic syndrome, as risk factors.METHODS: A systematic literature search of papers published between January 1, 1990 and January 14, 2021 was conducted using PubMed and Embase. Studies were eligible if they were published in English and were case-control or cohort studies. The exposures of interest were maternal overweight or obesity, hypertension, preeclampsia, diabetes, dyslipidaemia, and/or metabolic syndrome, and the outcome of interest was CHDs in the offspring. Furthermore, the studies were included according to a quality assessment score.RESULTS: Of the 2,250 identified studies, 32 qualified for inclusion. All but one study investigated only the individual metabolic disorders. Some disorders (obesity, gestational diabetes, and hypertension) increased risk of CHDs marginally whereas pre-gestational diabetes and early-onset preeclampsia were strongly associated with CHDs, without consistent differences between CHD subtypes. A single study suggested a possible additive effect of maternal obesity and gestational diabetes.CONCLUSIONS: Future studies of the role of aberrations of the glucose-insulin homeostasis in the common aetiology and mechanisms of metabolic disorders, present during pregnancy, and their association, both as single conditions and-particularly-in combination, with CHDs are needed.",
author = "Gitte Hedermann and Hedley, {Paula L} and Thagaard, {Ida N} and Lone Krebs and Ekelund, {Charlotte Kvist} and S{\o}rensen, {Thorkild I A} and Michael Christiansen",
note = "Publisher Copyright: {\textcopyright} 2021 Hedermann et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = may,
day = "27",
doi = "10.1371/journal.pone.0252343",
language = "English",
volume = "16",
pages = "1--22",
journal = "PLOS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

RIS

TY - JOUR

T1 - Maternal obesity and metabolic disorders associate with congenital heart defects in the offspring

T2 - A systematic review

AU - Hedermann, Gitte

AU - Hedley, Paula L

AU - Thagaard, Ida N

AU - Krebs, Lone

AU - Ekelund, Charlotte Kvist

AU - Sørensen, Thorkild I A

AU - Christiansen, Michael

N1 - Publisher Copyright: © 2021 Hedermann et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/5/27

Y1 - 2021/5/27

N2 - BACKGROUND: Congenital heart defects (CHDs) are the most common congenital malformations. The aetiology of CHDs is complex. Large cohort studies and systematic reviews and meta-analyses based on these have reported an association between higher risk of CHDs in the offspring and individual maternal metabolic disorders such as obesity, diabetes, hypertension, and preeclampsia, all conditions that can be related to insulin resistance or hyperglycaemia. However, the clinical reality is that these conditions often occur simultaneously. The aim of this review is, in consequence, both to evaluate the existing evidence on the association between maternal metabolic disorders, defined as obesity, diabetes, hypertension, preeclampsia, dyslipidaemia and CHDs in the offspring, as well as the significance of combinations, such as metabolic syndrome, as risk factors.METHODS: A systematic literature search of papers published between January 1, 1990 and January 14, 2021 was conducted using PubMed and Embase. Studies were eligible if they were published in English and were case-control or cohort studies. The exposures of interest were maternal overweight or obesity, hypertension, preeclampsia, diabetes, dyslipidaemia, and/or metabolic syndrome, and the outcome of interest was CHDs in the offspring. Furthermore, the studies were included according to a quality assessment score.RESULTS: Of the 2,250 identified studies, 32 qualified for inclusion. All but one study investigated only the individual metabolic disorders. Some disorders (obesity, gestational diabetes, and hypertension) increased risk of CHDs marginally whereas pre-gestational diabetes and early-onset preeclampsia were strongly associated with CHDs, without consistent differences between CHD subtypes. A single study suggested a possible additive effect of maternal obesity and gestational diabetes.CONCLUSIONS: Future studies of the role of aberrations of the glucose-insulin homeostasis in the common aetiology and mechanisms of metabolic disorders, present during pregnancy, and their association, both as single conditions and-particularly-in combination, with CHDs are needed.

AB - BACKGROUND: Congenital heart defects (CHDs) are the most common congenital malformations. The aetiology of CHDs is complex. Large cohort studies and systematic reviews and meta-analyses based on these have reported an association between higher risk of CHDs in the offspring and individual maternal metabolic disorders such as obesity, diabetes, hypertension, and preeclampsia, all conditions that can be related to insulin resistance or hyperglycaemia. However, the clinical reality is that these conditions often occur simultaneously. The aim of this review is, in consequence, both to evaluate the existing evidence on the association between maternal metabolic disorders, defined as obesity, diabetes, hypertension, preeclampsia, dyslipidaemia and CHDs in the offspring, as well as the significance of combinations, such as metabolic syndrome, as risk factors.METHODS: A systematic literature search of papers published between January 1, 1990 and January 14, 2021 was conducted using PubMed and Embase. Studies were eligible if they were published in English and were case-control or cohort studies. The exposures of interest were maternal overweight or obesity, hypertension, preeclampsia, diabetes, dyslipidaemia, and/or metabolic syndrome, and the outcome of interest was CHDs in the offspring. Furthermore, the studies were included according to a quality assessment score.RESULTS: Of the 2,250 identified studies, 32 qualified for inclusion. All but one study investigated only the individual metabolic disorders. Some disorders (obesity, gestational diabetes, and hypertension) increased risk of CHDs marginally whereas pre-gestational diabetes and early-onset preeclampsia were strongly associated with CHDs, without consistent differences between CHD subtypes. A single study suggested a possible additive effect of maternal obesity and gestational diabetes.CONCLUSIONS: Future studies of the role of aberrations of the glucose-insulin homeostasis in the common aetiology and mechanisms of metabolic disorders, present during pregnancy, and their association, both as single conditions and-particularly-in combination, with CHDs are needed.

UR - http://www.scopus.com/inward/record.url?scp=85106754802&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0252343

DO - 10.1371/journal.pone.0252343

M3 - Review

C2 - 34043700

VL - 16

SP - 1

EP - 22

JO - PLOS ONE

JF - PLOS ONE

SN - 1932-6203

IS - 5

M1 - e0252343

ER -

ID: 65796367